134 related articles for article (PubMed ID: 2675819)
1. Fansimef in the treatment of malaria.
Prociv P
Aust N Z J Med; 1989 Aug; 19(4):411. PubMed ID: 2675819
[No Abstract] [Full Text] [Related]
2. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
[TBL] [Abstract][Full Text] [Related]
3. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
Ellis-Pegler RB; Beeching NJ; Eales M; Fraser AG; Wells AU
Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
[No Abstract] [Full Text] [Related]
4. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial of fansimef in Indian patients of P. falciparum malaria.
Asthana OP; Tangri AN; Nityanand S
Indian J Malariol; 1988 Dec; 25(2):89-96. PubMed ID: 3077373
[No Abstract] [Full Text] [Related]
7. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
[TBL] [Abstract][Full Text] [Related]
8. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
[TBL] [Abstract][Full Text] [Related]
9. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
Niklewski G; Landscheidt H; Glasner H
Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058
[No Abstract] [Full Text] [Related]
10. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
Salako LA; Aderounmu AF; Laoye JO; Makinde JM; Adio RA
Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441
[TBL] [Abstract][Full Text] [Related]
12. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
[TBL] [Abstract][Full Text] [Related]
13. A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar.
Dixon KE; Williams RG; Pongsupat T; Pitaktong U; Phintuyothin P
Trans R Soc Trop Med Hyg; 1982; 76(5):664-7. PubMed ID: 6758224
[TBL] [Abstract][Full Text] [Related]
14. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
Tin F; Hlaing N; Tun T; Win S; Lasserre R
Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
[TBL] [Abstract][Full Text] [Related]
15. Problems with pyrimethamine/sulfadoxine malaria prophylaxis.
Lelijveld J
Lancet; 1982 Apr; 1(8277):915. PubMed ID: 6122136
[No Abstract] [Full Text] [Related]
16. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
[TBL] [Abstract][Full Text] [Related]
17. Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Arnold K
Lancet; 1985 Mar; 1(8430):704. PubMed ID: 2858655
[No Abstract] [Full Text] [Related]
18. Falciparum malaria resistant to quinine and pyrimethamine-sulfadoxine successfully treated with mefloquine.
Malin AS; Hall AP
BMJ; 1990 May; 300(6733):1175. PubMed ID: 2189516
[No Abstract] [Full Text] [Related]
19. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis.
Win K; Thwe Y; Lwin TT; Win K
Lancet; 1985 Sep; 2(8457):694-5. PubMed ID: 2863679
[No Abstract] [Full Text] [Related]
20. Double-blind studies with mefloquine alone and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam.
Trinh KA; Nguyen VK; Arnold K; Vo VC; Nguyen NB; Kim T; Ladinsky J
Trans R Soc Trop Med Hyg; 1990; 84(1):50-3. PubMed ID: 2189246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
